Success Stories

A shortage of lifestyle change coaches to implement CDC's Diabetes Prevention Program led CPESN Alabama leaders to offer free coach training. Lead Luminary Patrick Devereux says the network believes that having 15 certified coaches will lead to Medicare MCO and commercial payer opportunities.

Documentation of a blood pressure reading for nearly 1,000 patients by the end of year is the goal for 100 CPESN Florida pharmacies as part of a new managed MCO program. Laura Rhodes, Managing Network Facilitator, hopes the program will lead to more opportunities in 2023.

CPESN® West Virginia pharmacist Amber Conrad describes how the extension of a grant-funded Naloxone dispensing program allows her network's pharmacies to serve their communities. The program is funded through the West Virginia Drug Invention Institute and the West Virginia Department of Health.

Improved medication adherence for patients with diabetes is the goal of a new Medicaid managed care pilot program for CPESN North Carolina pharamcists. Amina Abubakar, owner of Avant Pharmacy & Wellness in Charlotte and a North Carolina luminary, describes the network opportunity.

Increased adherence to oral anticoagulants in Medicare AFib patients is the goal of a new multi-partner program for CPESN® North Carolina. The collaborative includes the CPESN Clinically Integrated Network (CIN), a pharmaceutical manufacturer, a health insurer, and a large health system. Luminary Jessi Stout, owner of Table Rock Pharmacy in Morganton, NC, describes the opportunity.

Eric Hughes, project manager with CPESN® Arkansas, describes a new contract for that network with CSS Health. Network pharmacies will provide comprehensive and targeted medication reviews for identified patients with reporting through the CSS MTM platform. 36 pharmacies are enrolled and other interested Arkansas network pharmacies should contact Eric at ehughes@cpesn.com.

CPESN Texas Pharmacist Laura Temple, owner of Laura's Pharmacy in Azle, TX, describes how using Asthma Severity Technology as part of a network pilot program helped her adjust medications and improve the outcome for a patient.

With the 4th-year renewal of a partnership with the South Dakota Dept. of Health, CPESN South Dakota pharmacists will take the successful cardiovascular disease program and their services into the communities where they will educate and screen for CVD risk.

A new contract with a clinical trial research group offers CPESN Utah pharmacies an opportunity to identify and refer qualifying patients for participation in drug development research.

Pharmacists in the CPESN® Pennsylvania network are delivering services under their full scope of practice in that state under an expanded program with a long-standing Medicaid MCO payer-partner. The long-term goal is to transition to pharmacists as plan providers with medical billing.

CPESN® USA Director of Value Based Contracting, Alison Haas, pharmacist & owner of Jackson Pharmacy & Wellness Center in Jackson Center, Ohio, highlights the expansion of the CPESN partnership with Mobility Health to all CPESN pharmacies across the country. Mobility provides lab services to support COVID-19 and flu testing.

In our 100th success video, CPESN® Utah Managing Network Facilitator, Benjamin Jolley, pharmacist with Jolley's Compounding Pharmacy in Salt Lake City, shares a unique success story about pharmacists becoming recognized as Medicaid providers and a new budgeted mandate in Utah directing that state's Medicaid program to pay pharmacists billing under CPT codes for Medication Therapy Management.

Roger Paganelli, CPESN USA Luminary and CPESN NYC pharmacist and coowner of Mt. Carmel Pharmacy in the Bronx, describes how two Bronx pharmacies will raise patient awareness about clinical trial opportunities, focusing particularly on health equity in underserved populations. The opportunity is part of a CPESN® USA national contract with Inside Edge Consulting, a company working with pharmaceutical sponsors of clinical drug trials. (4:45).

About 30 pharmacies enrolled in the EngageDr. program, exclusive to CPESN® USA participants, are offering early Alzheimer's and dementia screening to their patients. Funding is through a Davos Alzheimer's grant to Avant Institute. Pharmacies provide 10-minute self-screening, review results, and make referrals to physicians.

Martha Mosher, pharmacist and owner of the El Paso Medicine Shoppe, credits CPESN® Texas and its partnership with the University of Texas for preparing her pharmacy to offer its first clinical program - Diabetes Self Management Education.

CPESN® Indiana luminary Ryan Engleking, owner of Engleking Rx in Mitchell, Indiana, describes two payer programs his network has implemented with a Medicaid Managed Care plan. CPESN pharmacies provide smoking cessation patient counseling and Diabetes Self Management Education (DSME) services.

CPESN® Ohio luminary Jeff Neidig, owner of Medi-Wise Pharmacy in Newcomerstown, Ohio, shares information on the CPESN® USA Partnership with the CDC Office on Smoking and Health and the Tips from Former Smokers® campaign.

CPESN® Texas pharmacist, Sirisha Kandi, owner of Fiesta MLK Pharmacy in Dallas, describes a clinical trial recruitment "win-win" for patients and her pharmacy through RxE2 program (2:33).

CPESN® Texas luminary Ben McNabb, owner of Love Oak Pharmacy, describes his network's success implementing a Medicare Managed Care pilot program. Twelve pharmacies statewide provide medication adherence and enhanced services focusing on diabetes, asthma, and depression.

Arkansas CPESN® pharmacist Duane Jones from Harps Pharmacy describes his pharmacies' success utilizing the CPESN exclusive EngageDr. program and contracting with local physician groups.

CPESN® Michigan pharmacist Arun Tandon from Advanced Health Pharmacy describes his network's success working with Genemarkers to offer Pharmacogenetic (PGx) Testing.

CPESN® Connecticut luminary Ed Schreiner, owner of Stoll's Pharmacy in Waterbury, Connecticut describes his network's success working with RxE2 and recruiting patients for clinical trials (4:48).

Paula Boettler with Mitchell's Drug Stores in Neosho, Missouri and member of CPESN® Missouri describes how her fellowship helped her pharmacy energize their technicians and revamp their Med Sync program.

RxE2 CEO Gerald Finken shares his perspective on community-based pharmacies being ideal for recruiting and managing medications for patients on clinical trials, while adding a revenue stream for their pharmacy practices (5:15).

CPESN® New York City lead luminary and pharmacy owner Roger Paganelli shares the impact of CPESN-USA's participation in the CDC Federal Retail Pharmacy Partner Program. From February 2021 to June 7, 2022, CPESN pharmacies administered 5,585,754 vaccines, driving new traffic and opportunties.

CPESN® Ohio pharmacist Matt Mitchell describes his pharmacies' participation in CPESN® USA's first nationwide payer program. The national plan's goal was to increase medication adherence in maintenance behavioral health patients, and those taking medications to control hypertension, diabetes, or cholesterol. CPESN pharmacies achieved the highest performance bonus out of 3 possibilities during 2020 and 2021 programs, and improved STAR ratings.

CPESN® Hawaii luminary Dana Wong-Otis shares her experiences participating in the NCPA Innovation Center/CPESN Community Pharmacy Fellowship program (5:00).

CPESN® California luminary Sanjay Patel shares his network's success in working with the CDC Office of Smoking and Health to raise patient and community awareness about the health impact of smoking through the Tips from Former Smokers® Program (2:30).

Pennsylvania Pharmacists Care Network Executive Director Stephanie McGrath shares her network's success providing Comprehensive Medication Reviews for patients qualifying under Medicaid and Medicare, or dual eligible patients.

CPESN® Iowa Managing Network Facilitator Lindsey Ludwig shares her network's success participating in a state-wide medication disposal program in collaboration with DisposeRx. The program targets patients at risk for misuse or accidental overdose of opioids or other controlled substances.
(2:33).